- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT04212754
Management and Outcomes Following Emergency Surgery for Traumatic Brain Injury (GNOS)
Management and Outcomes Following Emergency Surgery for Traumatic Brain Injury - a Multi-centre, International, Prospective Cohort Study (the Global Neurotrauma Outcomes Study)
Primary aim:
The primary aim of the study is to compare survival to discharge (or survival to 14 days post-operatively, whichever comes first) following emergency surgery for traumatic brain injury (TBI) across Human Development Index settings.
Primary outcome measure:
The primary outcome measure will be survival to discharge (or survival to 14 days post-operatively, whichever comes first)
Primary comparison:
Between country groups defined by human development index.
Centre eligibility:
Any hospital or clinic worldwide performing emergency surgery for traumatic brain injury is eligible to participate.
Patient eligibility:
All adult and paediatric patients admitted to the participating institution with a traumatic brain injury for which they receive emergency surgery during the selected 30-day inclusion period are eligible for inclusion in the study.
Team:
Individual hospital teams with up to four people, collecting data for 30 days.
Time period:
Local study teams may select any 30-day period from the 1st of November 2018 and the 31st of December 2019 to start their study. Patients operated on who meet the inclusion criteria between 00:01 on day 0 and 23:59 on day 30 of the selected study period will be included.
Validation:
We will employ a method of data validation in every centre that will give us a quantitative estimate of case ascertainment that is feasible even in low-resource centres.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Voraussichtlich)
Kontakte und Standorte
Studienkontakt
- Name: David Clark
- Telefonnummer: +441223336946
- E-Mail: gnos@globalneurotrauma.com
Studienorte
-
-
Cambridgeshire
-
Cambridge, Cambridgeshire, Vereinigtes Königreich, CB2 0QQ
- Rekrutierung
- University of Cambridge
-
Kontakt:
- David Clark
- Telefonnummer: +441223336946
- E-Mail: gnos@globalneurotrauma.com
-
Kontakt:
- Peter Hutchinson
- Telefonnummer: +441223336946
- E-Mail: gnos@globalneurotrauma.com
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Kind
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Centre Inclusion Criteria:
Any hospital or clinic worldwide performing emergency surgery for traumatic brain injury is eligible to participate. In the majority of institutions, emergency surgery for TBI is provided by neurosurgeons - however, centres in which emergency surgery for TBI is provided general surgeons, trauma surgeons, general medical doctors or even non-physician clinicians are also eligible to participate.
Inclusion Criteria:
- All adult and paediatric patients admitted to the participating institution with a traumatic brain injury for which they receive emergency surgery during the selected 30-day inclusion period are eligible for inclusion in the study.
Exclusion Criteria:
- Patients who only have an external ventricular drain or intraparenchymal wire (or other monitoring device) inserted for the diagnosis and/or management of intracranial hypertension.
- Patients who undergo procedures for chronic subdural haematoma(s), including burr holes or mini-craniotomies.
- Elective (planned admission) or semi-elective (where patient initially admitted as an emergency, then discharged from hospital, and re-admitted at later time for surgery) procedures.
- Patients who have previously had emergency cranial surgery for traumatic brain injury rendering them eligible for inclusion in this study (regardless of whether they were included)
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
---|---|
Procedure: Emergency surgery for traumatic brain injury
|
Primärer Vergleich: Zwischen Ländergruppen, definiert durch den Index der menschlichen Entwicklung.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
---|---|
In-hospital mortality (or 14 day mortality, whichever comes first)
Zeitfenster: Up until hospital discharge, death or 14 days postoperatively, whichever comes first
|
Up until hospital discharge, death or 14 days postoperatively, whichever comes first
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Perioperative complications: Return to operating theatre
Zeitfenster: Up until hospital discharge, death or 14 days postoperatively, whichever comes first
|
Including reason for return.
|
Up until hospital discharge, death or 14 days postoperatively, whichever comes first
|
Perioperative complications: Surgical site infection (SSI)
Zeitfenster: Up until hospital discharge, death or 14 days postoperatively, whichever comes first
|
SSI is stratified into superficial and deep/organ space infection.
|
Up until hospital discharge, death or 14 days postoperatively, whichever comes first
|
Length of stay in hospital (days)
Zeitfenster: Up until hospital discharge, death or 14 days postoperatively, whichever comes first
|
Up until hospital discharge, death or 14 days postoperatively, whichever comes first
|
|
Length of stay in intensive care (days)
Zeitfenster: Up until hospital discharge, death or 14 days postoperatively, whichever comes first
|
For patients admitted to intensive care.
|
Up until hospital discharge, death or 14 days postoperatively, whichever comes first
|
Glasgow Coma Score at discharge/end of follow up period
Zeitfenster: At hospital discharge 14 days postoperatively, whichever comes first
|
3-15, 3 signifies no eye opening, verbal response or motor response to painful stimulus, 15 signifies no impairment to consciousness.
For patients surviving to discharge and/or 14 days postoperatively.
|
At hospital discharge 14 days postoperatively, whichever comes first
|
Location that the patient was discharged to
Zeitfenster: Within 14 days post-operatively, only applies to patients who are discharged within this time period.
|
For patients surviving to discharge and discharged within 14 days post-operatively.
Categorical variable for which the options are 'transfer to another hospital', 'transfer to rehabilitation unit', 'usual place of residence' and 'absconded'.
A surrogate measure of short term functional outcome.
|
Within 14 days post-operatively, only applies to patients who are discharged within this time period.
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: David Clark, University of Cambridge
- Hauptermittler: Peter Hutchinson, University of Cambridge
- Hauptermittler: Alexis Joannides, University of Cambridge
- Hauptermittler: Angelos Kolias, University of Cambridge
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- GNOS1
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
IPD-Sharing-Zeitrahmen
Art der unterstützenden IPD-Freigabeinformationen
- STUDIENPROTOKOLL
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Hirnverletzungen
-
National Institute of Mental Health (NIMH)AbgeschlossenBrain-MappingVereinigte Staaten
-
National Institute on Alcohol Abuse and Alcoholism...AbgeschlossenBrain-MappingVereinigte Staaten
-
University of Dublin, Trinity CollegeUnbekanntBrain Health Elite-Athleten im Ruhestand
-
Assistance Publique Hopitaux De MarseilleUnbekanntBrain Awake-ChirurgieFrankreich
-
National Institute of Mental Health (NIMH)RekrutierungGesunder Freiwilliger | Brain-MappingVereinigte Staaten
-
National Institute of Neurological Disorders and...RekrutierungGesund | Magnetresonanztomographie | Gesunder Freiwilliger | Erwachsene | fMRT | Brain-MappingVereinigte Staaten
-
National Institute of Neurological Disorders and...AbgeschlossenGesund | Blindheit | Brain-MappingVereinigte Staaten
-
National Institute on Alcohol Abuse and Alcoholism...RekrutierungAlkohol trinken | Alkoholabhängigkeit | Alkoholismus | Alkoholbedingte Störungen | Brain-MappingVereinigte Staaten
-
National Institute of Mental Health (NIMH)AbgeschlossenfMRT | Gehirnerkrankung | Brain-Mapping | Genotyp | Allelic Frequencies of Genetic MarkersVereinigte Staaten
-
Assiut UniversityAbgeschlossenBrain Voxel-basierte Morphometrie bei ManiaÄgypten